CSI Market
Sign In | Register

Aim Immunotech Inc (AIM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AIM Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Aim Immunotech Inc's financial structure and capital allocation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent5.82
Marketable Securities, Current SH0.06
Cash & Short-term Investments5.00
Accounts receivable0.00
Other Receivables, Net, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.34
Total Current Assets6.21
Equipment/Property/Plant Net0.06
Intangible Assets1.66
Other Assets, Noncurrent0.65
Operating Lease Right Of Use Asset0.32
Total Assets8.59
Liabilities
Accounts Payable, Current AC1.22
Accrued Liabilities, Current AC0.67
Notes Payable, Current NO4.00
Total Current Liabilities6.15
Long-term debt0.21
Total Long-term Debt0.21
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent0.36
Operating Lease Liability Current0.26
Operating Lease Liability Noncurrent0.11
Total Liabilities6.46
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock445.93
Retained Earnings / Accumulated Deficit-443.81
Other Equity0.00
Common Stockholder's Equity2.13
Total Stockholder's Equity2.13
Liabilities & Stockholder's Equity8.59
4 historic quarters locked

Sign in to unlock the full Aim Immunotech Inc balance sheet history.

Sign In Create Free Account

About Aim Immunotech Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 7, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-036609

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.